President-elect Donald Trump has put forward a formal pick for the top spot at the U.S. Food and Drug Administration. | ...

While Johnson & Johnson hopes to soon resolve more than 60,000 talc lawsuits with an $8 billion bankruptcy settlement in the ...

As the biopharma industry braces for a second term under President-elect Donald Trump, speculation is swirling around the ...

For Big Pharma, recent headlines out of China suggest multinational drugmakers are facing their share of challenges in the ...

While president-elect Donald Trump has already made his leadership picks for the Department of Health and Human Services (HHS ...

With Spanish plasma specialist Grifols turning down a potential multi-billion-dollar takeover bid, it’s likely back to the ...

New York-based health comms agency Calcium+Company is living up to its name, strengthening the bones of its business with the ...

Every year, Fierce’s pharma, biotech, and medtech teams come together to spotlight some of the fiercest women in life s | ...

Triple-negative breast cancer, or TNBC, is a rare and especially aggressive form of breast cancer that grows and spreads ...

Few pharmaceutical products have taken the market by storm like Roche’s Vabysmo. | Interim results from a late-stage trial of ...

It was only last October that UCB’s up-and-coming immunology powerhouse Bimzelx first crossed the FDA finish line in ...